Rob Dillard

DocwireNews

Machine-learning algorithms indicate that 90% of Medicare beneficiaries with opioid prescriptions have a low risk of overdose, according to a study <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2728625">published</a> in JAMA.In this prognostic study conducted between September 2017 and December 2018, researchers evaluated the administrative claims data of 560,057 (mean age, 68, 63% female, 82% white) Medicare beneficiaries without cancer who filled one or more opioid prescriptions from January 2011 to December 2015. The beneficiaries were arbitrarily and equally partitioned into training (n=186,686), testing (n=186,685), and validation (n=186,686) samples. The researchers measured potential predictors (n=268), including socio-demographics, health status, patterns of opioid use, and practitioner-level and regional-level factors in three-month windows, and began the assessment three months prior to initiating opioids, until loss of follow-up or until the conclusion of the observation.Opioid overdose occurrences from inpatient and emergency department claims were identified before researchers used multivariate logistic regression (MLR), least absolute shrinkage and selection operator-type regression (LASSO), random forest (RF), gradient boosting machine (GBM), and deep neural network (DNN) to project overdose risk in the subsequent three months after the start of treatment with prescription opioids. Additionally, researchers gauged prediction performance using the C statistic and other metrics such as sensitivity, number needed to evaluate (NNE) to identify one overdose, and specificity.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Benef&hellip; <a href="https://t.co/kBAlB3zaxX">https://t.co/kBAlB3zaxX</a> <a href="https://twitter.com/hashtag/ai?src=hash&amp;ref_src=twsrc%5Etfw">#ai</a> <a href="https://twitter.com/hashtag/ml?src=hash&amp;ref_src=twsrc%5Etfw">#ml</a> <a href="https://twitter.com/hashtag/dl?src=hash&amp;ref_src=twsrc%5Etfw">#dl</a>
&mdash; AI News Feed (@AINewsFeed) <a href="https://twitter.com/AINewsFeed/status/1109172091188928512?ref_src=twsrc%5Etfw">March 22, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><h2>Minimal Overdose Episodes in Low-Risk Group</h2>In the validation sample, the study&rsquo;s results suggest the DNN (C statistic=0.91; 95% CI, 0.88 to 0.93) and GBM (C statistic=0.90; 95% CI, 0.87 to 0.94) algorithms outperformed the LASSO (C statistics=0.84; 95% CI, 0.80 to 0.89), RF (C statistic=0.80; 95% CI, 0.75 to 0.84), and MLR (C statistic=0.75; 95% CI, 0.69 to 0.80) methods for predicting opioid overdose. Moreover, in optimized sensitivity and specificity, DNN had a sensitivity of 92.3%, specificity of 75.7%, NNE of 542, positive predictive value of 0.18%, and negative predictive value of 99.9%.Furthermore, the DNN categorized patients into low-risk (76.2% [142,180] of the cohort), medium-risk (18.6% [34,579] of the cohort), and high-risk (5.2% [9,747] of the cohort) subgroups, with only one in 10,000 in the low-risk subgroup incurring an overdose episode. More than 90% of overdose episodes occurred in the high-risk and medium-risk subgroups, although positive predictive values were low, given the rare overdose outcome.&ldquo;For those in the high-and medium-risk groups, although most will be false-positives for overdose given the overall low prevalence, additional screening and assessment may be warranted,&rdquo; researchers wrote about the study&rsquo;s results. &ldquo;Although certainly not perfect, these machine-learning models allow interventions to be targeted to the small number of individuals who are at greater risk, and these models are more useful than other prediction criteria that have considerably more false-positives.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
"Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions" <a href="https://t.co/lqqwcLHSoE">https://t.co/lqqwcLHSoE</a>
&mdash; badc0da (@badc0da) <a href="https://twitter.com/badc0da/status/1109435598576726018?ref_src=twsrc%5Etfw">March 23, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>https://twitter.com/TheATIPUSA/status/1109623001056727041

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Machine-Learning Algorithms Can Predict Opioid Overdose Risk

Pharmacology

Machine-learning algorithms indicate that 90% of Medicare beneficiaries with opioid prescriptions have a low risk of overdose, according to a study published in JAMA. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe